Pharmaceutical manufacturers are tasked with monitoring and reporting safety events (adverse events, product quality complaints, special situations, etc.) to protect patient safety. This process – detecting, documenting, evaluating, reporting, and following up – is essential to meeting regulatory standards and ensuring optimal patient outcomes. However, many of these critical events are not being captured today. …
Why hospital biobanks should supply biotechs
When it comes to using biospecimens for research, the saying “garbage in, garbage out” applies (Compton, 2018). This maxim has been a driving force in biospecimen science: a field in which the focus is pre-analytical factors affecting biospecimen quality. It has also been a driving force in the professionalization of biobanking. As a result, the…
What’s driving the natural language processing revolution in pharma and life sciences
Pharmaceutical and life sciences companies are faced with a constant stream of new data flowing into often siloed information systems. About 80% of that information exists in unstructured text that is difficult to extract and use, despite its paramount importance in driving clinical and commercial outcomes. As a result, these organizations find themselves increasingly overwhelmed…